United States - Patent - FTC Challenges More Patent Listings In The FDA's Orange Book

The Federal Trade Commission (FTC) has been busy scrutinizing patent listings in the Food and Drug Administration's (FDA) publication of "Approved Drug Products with Therapeutic Equivalence Evaluations...

Related Keywords

,Drug Administration ,Key Takeaways ,Orange Book ,Federal Trade Commission ,Drug Products ,Equivalence Evaluations ,Policy Statement ,Hatch Waxman Act ,